AsOf

Recorded or changed on this day 2026-11-08

44,751–44,800 of 46,537 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total assets · 377,716,000,000 United States dollar
Verizon total assets: 377,716,000,000 United States dollar, claim clm_F46F2E2981B5 · ended · superseded by clm_2A96EF117616 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · net income · 6,428,000,000 United States dollar
Verizon net income: 6,428,000,000 United States dollar, claim clm_F4764460A6C3 · ended · superseded by clm_1C1E55807EF1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly revenue · 24,124,000,000 United States dollar
Verizon quarterly revenue: 24,124,000,000 United States dollar, claim clm_F4F64B391F7B · ended · superseded by clm_82FCD8E3CB50 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly operating income · 8,242,000,000 United States dollar
Verizon quarterly operating income: 8,242,000,000 United States dollar, claim clm_F57DB6A68787 · ended · superseded by clm_2A973B1C9C6B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · cash and equivalents · 1,153,000,000 United States dollar
Verizon cash and equivalents: 1,153,000,000 United States dollar, claim clm_F57EC253C385 · ended · superseded by clm_779D4BECB2A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · revenue · 120,550,000,000 United States dollar
Verizon revenue: 120,550,000,000 United States dollar, claim clm_F5F3CE821FAF · ended · superseded by clm_C9511B7D0CF4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · shares outstanding · 4,131,896,508 shares
Verizon shares outstanding: 4,131,896,508 shares, claim clm_F621A1A24C79 · ended · superseded by clm_E037B563797B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total equity · 14,542,000,000 United States dollar
Verizon total equity: 14,542,000,000 United States dollar, claim clm_F6E1FD5FEAA6 · ended · superseded by clm_73569C18B39D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total equity · 52,345,000,000 United States dollar
Verizon total equity: 52,345,000,000 United States dollar, claim clm_F79DA9890954 · ended · superseded by clm_23936429301B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total equity · 82,869,000,000 United States dollar
Verizon total equity: 82,869,000,000 United States dollar, claim clm_F8BFBEB86C36 · ended · superseded by clm_190A5B0EAC69 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · cash and equivalents · 7,218,000,000 United States dollar
Verizon cash and equivalents: 7,218,000,000 United States dollar, claim clm_F9BF46E46330 · ended · superseded by clm_6ABCD3336B68 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · cash and equivalents · 2,907,000,000 United States dollar
Verizon cash and equivalents: 2,907,000,000 United States dollar, claim clm_FA4010DAD364 · ended · superseded by clm_1318EE95A6FB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · net income · 875,000,000 United States dollar
Verizon net income: 875,000,000 United States dollar, claim clm_FAA8A2CD453B · ended · superseded by clm_5E04CFA9B570 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly net income · 1,593,000,000 United States dollar
Verizon quarterly net income: 1,593,000,000 United States dollar, claim clm_FAFF52CCE332 · ended · superseded by clm_61A819ABB6AA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total equity · 84,473,000,000 United States dollar
Verizon total equity: 84,473,000,000 United States dollar, claim clm_FB30C90A1281 · ended · superseded by clm_0D8BCADB2FB7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · revenue · 93,469,000,000 United States dollar
Verizon revenue: 93,469,000,000 United States dollar, claim clm_FB4D10884896 · ended · superseded by clm_51997D597FCA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total assets · 366,596,000,000 United States dollar
Verizon total assets: 366,596,000,000 United States dollar, claim clm_FBD0CDA5552C · ended · superseded by clm_A2F830C3B10A · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Verizon · headquarters · New York City
Verizon headquarters: New York City, claim clm_FC161DBD9138 · valid · 2 sources (1 primary) · conf 0.80
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly revenue · 27,913,000,000 United States dollar
Verizon quarterly revenue: 27,913,000,000 United States dollar, claim clm_FC6A5E9ED96A · ended · superseded by clm_E8694B32255E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · total assets · 345,573,000,000 United States dollar
Verizon total assets: 345,573,000,000 United States dollar, claim clm_FD9CCB742C72 · ended · superseded by clm_F3622F5FE5F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly revenue · 26,861,000,000 United States dollar
Verizon quarterly revenue: 26,861,000,000 United States dollar, claim clm_FD9F3CFE799D · ended · superseded by clm_C20DF02D6008 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · quarterly revenue · 32,912,000,000 United States dollar
Verizon quarterly revenue: 32,912,000,000 United States dollar, claim clm_FE791472ADDC · ended · superseded by clm_06DCFDC2948E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Verizon · cash and equivalents · 56,710,000,000 United States dollar
Verizon cash and equivalents: 56,710,000,000 United States dollar, claim clm_FF97800FF35D · ended · superseded by clm_9486C1FDD417 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -171,164,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -171,164,000 United States dollar, claim clm_00535EE0B591 · ended · superseded by clm_A645F319F190 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 25,643,000,000 United States dollar
Vertex Pharmaceuticals total assets: 25,643,000,000 United States dollar, claim clm_0090178AE4A5 · ended · superseded by clm_263F86EB65D1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 15,630,900,000 United States dollar
Vertex Pharmaceuticals total equity: 15,630,900,000 United States dollar, claim clm_00AA213A3D85 · ended · superseded by clm_D2246EF67C62 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 949,828,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 949,828,000 United States dollar, claim clm_01DE6C70A804 · ended · superseded by clm_ED12A2E330B4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 3,546,014,000 United States dollar
Vertex Pharmaceuticals total assets: 3,546,014,000 United States dollar, claim clm_0222BA7D9859 · ended · superseded by clm_4E19B710DABA · 2 sources (2 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 254,251,938 shares
Vertex Pharmaceuticals shares outstanding: 254,251,938 shares, claim clm_02288182B0BB · ended · superseded by clm_075B175EC177 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 16,496,300,000 United States dollar
Vertex Pharmaceuticals total equity: 16,496,300,000 United States dollar, claim clm_030CF6670A5D · ended · superseded by clm_D44D3849A57A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,091,998,000 United States dollar
Vertex Pharmaceuticals total assets: 2,091,998,000 United States dollar, claim clm_0364D2508EA1 · ended · superseded by clm_15FE4534F8E1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 223,858,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 223,858,000 United States…, claim clm_03E4A3140826 · ended · superseded by clm_6E79D9B514B1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 123,243,000 United States dollar
Vertex Pharmaceuticals operating income: 123,243,000 United States dollar, claim clm_03E98C0A4208 · ended · superseded by clm_30D3676BC4AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 7,574,400,000 United States dollar
Vertex Pharmaceuticals revenue: 7,574,400,000 United States dollar, claim clm_054958897891 · ended · superseded by clm_AC7CF3A293FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 1,197,566,000 United States dollar
Vertex Pharmaceuticals operating income: 1,197,566,000 United States dollar, claim clm_05A793B89218 · ended · superseded by clm_227207794AE5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 1,724,305,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 1,724,305,000 United States dollar, claim clm_05E33637AD96 · ended · superseded by clm_BA95AEDBE337 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 746,115,000 United States dollar
Vertex Pharmaceuticals total equity: 746,115,000 United States dollar, claim clm_066255CCD67E · ended · superseded by clm_D261B9E53F59 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 73,662,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 73,662,000 United States dollar, claim clm_06E54341B7F1 · ended · superseded by clm_0CB375426AF0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 1,047,690,000 United States dollar
Vertex Pharmaceuticals research and development: 1,047,690,000 United States dollar, claim clm_070B60D12935 · ended · superseded by clm_C5B2018B6129 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 254,576,691 shares
Vertex Pharmaceuticals shares outstanding: 254,576,691 shares, claim clm_075B175EC177 · ended · superseded by clm_CD985C968363 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,691,452 shares
Vertex Pharmaceuticals shares outstanding: 256,691,452 shares, claim clm_07E003F90843 · ended · superseded by clm_3C5FD882584C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 458,195,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 458,195,000 United States dollar, claim clm_0816B23FB77A · ended · superseded by clm_51A871DDB6C2 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · total equity · 20,907,400,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · operating income · 4,173,300,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 255,860,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 255,860,000 United States…, claim clm_08C42F082050 · ended · superseded by clm_C3B5C13564FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 995,922,000 United States dollar
Vertex Pharmaceuticals research and development: 995,922,000 United States dollar, claim clm_09536F600AFF · ended · superseded by clm_070B60D12935 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 252,118,869 shares
Vertex Pharmaceuticals shares outstanding: 252,118,869 shares, claim clm_096340916E85 · ended · superseded by clm_40905FFA2E58 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 256,459,482 shares
Vertex Pharmaceuticals shares outstanding: 256,459,482 shares, claim clm_09C3E31B05ED · ended · superseded by clm_07E003F90843 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 15,582,200,000 United States dollar
Vertex Pharmaceuticals total assets: 15,582,200,000 United States dollar, claim clm_09D1A8C06700 · ended · superseded by clm_2C70611C367D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 5,988,187,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 5,988,187,000 United States dollar, claim clm_0A0A75CC866D · ended · superseded by clm_E30E4F36DF29 · 1 source (1 primary) · conf 0.95

What the statuses mean